Harish Shantharam - 18 Aug 2025 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role: Chief Financial Officer
Signature: /s/ Shelly Pinto, by power of attorney
Issuer symbol: ALXO
Transactions as of: 18 Aug 2025
Net transactions value: +$58,402
Form type: 4
Filing time: 20 Aug 2025, 16:02:05 UTC
Previous filing: 15 Apr 2025
Next filing: 16 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Shantharam Harish	Chief Financial Officer	C/O ALX ONCOLOGY HOLDINGS INC., 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO	/s/ Shelly Pinto, by power of attorney	20 Aug 2025	0001976391

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALXO	Common Stock	Purchase	$58,402	+75,000		$0.7787	75,000	18 Aug 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6823 to $0.9234, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6823 to $0.9234, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.